flubendazole has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, T; Cui, Y; Ge, C; Geng, Q; Jiang, G; Jiang, S; Jin, W; Li, H; Li, J; Lin, H; Liu, T; Mao, L; Miao, C; Su, Y; Xiao, X; Yu, J; Zhao, F | 1 |
1 other study(ies) available for flubendazole and Liver Neoplasms
| Article | Year |
|---|---|
Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Repositioning; Hedgehog Proteins; Humans; Liver Neoplasms; Proprotein Convertase 9 | 2023 |